From: Impact of discussion on preferences elicited in a group setting
 |  | Before discussion | After discussion | Difference | |||
---|---|---|---|---|---|---|---|
Health state | Description | Mean (SD) | Median (range) | Mean (SD) | Median (range) | Mean (SD) | Median |
1. | Multiple sclerosis state 1 | 0.75 (0.21) | 0.85 (0.48–1.0) | 0.83 (0.16) | 0.88 (0.48–1.0) | 0.08 (-0.01) | 0.03 |
2. | Multiple sclerosis state 2 | 0.94 (0.06) | 0.98 (0.85–1.0) | 0.93 (0.05) | 0.93 (0.85–1.0) | -0.01 (-0.05) | -0.05 |
3. | Gaucher's disease | 0.88 (0.14) | 0.93 (0.5–1.0) | 0.88 (0.14) | 0.93 (0.5–1.0) | 0 (0) | 0 |
4. | EQ5D state 1 | 0.97 (0.03) | 0.98 (0.9–1.0) | 0.98 (0.02) | 0.98 (0.93–1.0) | 0.01 (-0.01) | 0 |
5. | EQ5D state 2 | 0.3 (0.51) | 0.48 (-0.88–0.88) | 0.30 (0.51) | 0.48 (-0.88–0.88) | 0 (0) | 0 |
6. | EQ5D state 3 | 0.75 (0.19) | 0.83 (0.38–0.98) | 0.75 (0.20) | 0.83 (0.38–0.98) | 0 (0.01) | 0 |
7. | Heart failure state 1 | 0.84 (0.26) | 0.93 (0.05–0.98) | 0.84 (0.26) | 0.93 (0.05–0.98) | 0 (0) | 0 |
8. | Heart failure state 2 | 0.51 (0.42) | 0.56 (-0.68–0.93) | 0.50 (0.41) | 0.56 (-0.68–0.93) | -0.01 (-0.01) | 0 |
9. | Moderate eczema | 0.782 (0.22) | 0.88 (0.28–1.0) | 0.786 (0.22) | 0.88 (0.28–1.0) | 0.004 (0) | 0 |
10. | Severe eczema | 0.70 (0.23) | 0.68 (0.3–1.0) | 0.69 (0.21) | 0.68 (0.3–0.95) | -0.01 (-0.02) | 0 |
11. | Osteoarthritis state 1 | 0.96 (0.06) | 1.00 (0.83–1.0) | 0.96 (0.06) | 0.98 (0.83–1.0) | 0 (0) | -0.02 |
12. | Osteoarthritis state 2 | 0.83 (0.13) | 0.83 (0.58–1.0) | 0.83 (0.11) | 0.83 (0.68–1.0) | 0 (-0.02) | 0 |
13. | Osteoarthritis state 3 | 0.96 (0.04) | 0.98 (0.88–1.0) | 0.97 (0.03) | 0.98 (0.93–1.0) | 0.01 (-0.01) | 0 |
14. | Osteoarthritis state 4 | 0.98 (0.02) | 0.98 (0.93–1.0) | 0.98 (0.02) | 0.99 (0.93–1.0) | 0 (0) | 0.01 (0) |